[ad_1] A RSV-infected child receives treatment, as RS-Virus infections spread among children at Missio children’s clinic Moenchberg, in Wuerzburg, Germany, December 2, 2022. Heiko Becker | Reuters The Centers for Disease Control and Prevention expedited the release of more than 77,000 additional doses of a new drug designed to protect infants from respiratory syncytial virus…
[ad_1] Analysts are largely optimistic about a new class of anti-obesity medications following a landmark study released over the weekend. Novo Nordisk ‘s Select study of about 17,500 people found the use of its Wegovy decreased the risk of serious cardiovascular complications such as heart attacks. The study, which was shared at the American Heart…
[ad_1] Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity. It should be used with a weight loss plan and physical activity. Michael Siluk | UCG | Getty Images Novo Nordisk’s Wegovy cut the risk of serious cardiovascular complications in people with obesity and heart disease in a…
[ad_1] A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, on March 29, 2023. George Frey | Reuters The Food and Drug Administration on Wednesday approved Eli Lilly‘s blockbuster drug tirzepatide for weight loss, paving the way…
[ad_1] Elf Bar disposable vape flavored vaping e-cigarette products are displayed in a convenience store on June 23, 2022 in El Segundo, California. – Vaping company Juul Labs said Thursday it would appeal a decision by the US Food and Drug Administration ordering all its products off the market, a move the agency said was…
[ad_1] Unnamed smoker at 4th Street Live on July 24, 2023, in Louisville, KY. Jahi Chikwendiu | The Washington Post | Getty Images Only a fraction of people at high risk for lung cancer are getting screened for the disease even though it kills more in the United States than breast, colorectal and prostate cancers…
[ad_1] A vaccine from GlaxoSmithKline showed the potential to protect adults ages 50 to 59 from respiratory syncytial virus in a late-stage clinical trial, the company said Wednesday. The initial trial results suggest that GSK’s shot, known as Arexvy, could help protect a wider population from RSV, a disease that causes thousands of hospitalizations and…
[ad_1] Sdi Productions | E+ | Getty Images Many people will soon be picking their health insurance plans for 2024: November is a common month for workplace open enrollment, and the public marketplace opens Nov. 1. But choosing a health plan can be tricky. In fact, a 2017 study found many people lose money due…
[ad_1] The US Supreme Court in Washington, DC, on June 27, 2023. Kevin Dietsch | Getty Images WASHINGTON — The Supreme Court on Friday blocked in full a lower court ruling that would have curbed the Biden administration’s ability to communicate with social media companies about contentious content on such issues as Covid-19. The decision…
[ad_1] The Food and Drug Administration is proposing a ban on using formaldehyde as an ingredient in hair relaxers, a huge step in raising awareness about the potential harms such products create for the many Black women who typically use them. The proposed rule would ban the chemical in hair-smoothing or hair-straightening products, also called relaxers. The…
